Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis

• Status: Completed
• Trial end date: 2012-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

A multicenter, randomized, double-blind, active-controlled, phase III clinical trial to evaluate the efficacy and safety of Dp-R206 and Bonviva for 16 weeks once a month on the improvement of vitamin D in postmenopausal women with osteoporosis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alvogen Korea
• Treatments: Cholecalciferol; Ibandronic Acid; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Female more than 40 years old in postmenopausal

Exclusion Criteria:

• Subject who has a history of malignant cancer